BENEDETTI, MARIADONATA
 Distribuzione geografica
Continente #
NA - Nord America 3.378
EU - Europa 2.790
AS - Asia 1.414
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
AF - Africa 6
Totale 7.630
Nazione #
US - Stati Uniti d'America 3.369
CN - Cina 972
GB - Regno Unito 922
SE - Svezia 363
SG - Singapore 358
IT - Italia 319
RU - Federazione Russa 245
FR - Francia 236
IE - Irlanda 207
FI - Finlandia 199
DE - Germania 148
UA - Ucraina 56
BE - Belgio 29
BR - Brasile 14
VN - Vietnam 14
IR - Iran 12
CZ - Repubblica Ceca 10
NL - Olanda 10
KR - Corea 9
AU - Australia 7
ID - Indonesia 7
JP - Giappone 7
TR - Turchia 7
CH - Svizzera 6
DK - Danimarca 6
EU - Europa 6
GR - Grecia 6
IL - Israele 6
IN - India 6
CA - Canada 5
AT - Austria 4
CL - Cile 4
EC - Ecuador 4
PL - Polonia 4
BD - Bangladesh 3
BG - Bulgaria 3
ES - Italia 3
HK - Hong Kong 3
RO - Romania 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
DO - Repubblica Dominicana 2
KH - Cambogia 2
MA - Marocco 2
TG - Togo 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BO - Bolivia 1
BW - Botswana 1
CO - Colombia 1
CY - Cipro 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 7.630
Città #
Southend 809
Chandler 605
Jacksonville 418
Woodbridge 400
Singapore 305
Ann Arbor 301
Ashburn 261
Dublin 207
Houston 180
Beijing 130
Verona 102
Wilmington 96
New York 94
Lawrence 88
Princeton 88
Nanjing 82
Jinan 79
Hebei 74
Helsinki 72
Shenyang 61
Haikou 39
Tianjin 38
Ningbo 37
Boardman 36
Changsha 36
Brussels 29
Zhengzhou 29
Lancaster 27
Taiyuan 27
Hangzhou 26
Nanchang 26
Washington 26
Taizhou 25
Fuzhou 24
Milan 23
Sindelfingen 21
Redmond 20
Redwood City 20
Guangzhou 18
Jiaxing 18
Bologna 16
Norwalk 16
Auburn Hills 15
Falls Church 14
Lanzhou 14
Santa Clara 13
Düsseldorf 12
Seattle 12
Clearwater 11
Dallas 11
Los Angeles 11
Dong Ket 10
Moscow 10
Olomouc 10
Riva 10
Kemerovo 9
Seoul 8
Bolzano 7
Arco 6
Ardabil 6
Chicago 6
Fairfield 6
Kent 6
San Mateo 6
Dearborn 5
Jakarta 5
Paris 5
San Francisco 5
Tehran 5
Amsterdam 4
Dongguan 4
Genoa 4
Novokuznetsk 4
Rome 4
Augusta 3
Bari 3
Boston 3
Brescia 3
Champaign 3
Cleveland 3
Copenhagen 3
Giv‘atayim 3
Las Vegas 3
Macerata 3
Munich 3
Padova 3
Philadelphia 3
Puxian 3
Saint Louis 3
Sofia 3
Stockholm 3
Tokyo 3
Vienna 3
Wuhan 3
Alessano 2
Athens 2
Bentivoglio 2
Bethesda 2
Cambridge 2
Castelfiorentino 2
Totale 5.359
Nome #
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 176
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 144
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 138
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 123
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 122
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 119
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 116
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 114
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 112
Cognitive onset in multiple sclerosis 111
Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients 108
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 105
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 105
Effects of pulsed electromagnetic fields on nerve regeneration: an experimental study in the rat 104
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 103
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 102
A case of acute fulminant multiple sclerosis treated with alemtuzumab 102
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 101
Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro 101
Glial cell and macrophage reactions in rat spinal ganglion after peripheral nerve lesions: an immuno-cytochemical and morphometric study 101
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 101
Apporto della neurofisiologia allo studio delle disfunzioni dell'apparato uro-genitale 100
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 100
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 99
Multifactorial etiological aspects of epilepsy 98
Short term prognosis of stroke in a clinical series of 94 patients 98
Epilessia ed imaging 96
Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: a cross-sectional morphometric and immunohistochemical study in twenty cases 96
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 95
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 94
Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis. 93
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial 93
Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study 93
Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients. 92
Resting motor threshold in idiopathic generalized epilepsies: A systematic review with meta-analysis. 91
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 91
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis 90
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 90
Epilepsy in multiple sclerosis: The role of temporal lobe damage 90
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 89
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 89
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 88
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 88
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 88
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 86
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 86
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 86
A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble? 85
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 84
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study 84
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 84
Prevalence of dementia and apoliprotein E genotype distribution in the elderly of Buttapietra, Verona Province, Italy 83
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 83
Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. 81
Long survival and clinical stability in Marburg's variant multiple sclerosis. 80
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 80
Prognosi del Piccolo Male-assenze tipiche. Studio di follow-up su 60 casi. [Prognosis of pure petit mal. Follow-up study of 60 cases] 79
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 79
Prognostic factors of acute partial transverse myelitis. 78
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 78
COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk 77
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 77
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 77
A multicentric prospective incidence study of Guillain-Barré Syndrome in Italy. The ITANG Study 75
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 74
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study 74
Efficacia della monoterapia in pazienti epilettici di nuova diagnosi e precedentemente non trattati. Studio prospettico 73
Prognostic indicators of “benign” clinical course in multiple sclerosis patients. 71
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 70
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 70
Azathioprine in multiple sclerosis 68
Use of plasma levels for antiepileptic drug monitoring in clinical practice 68
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 68
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives 65
Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population. 64
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 63
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis 63
Treatment strategies for multiple sclerosis: when to start, when to change, when to stop? 62
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 62
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study. 61
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 59
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial 55
Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis 53
Reappraisal of Aβ40 and Aβ42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease 51
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. 50
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. 50
Trial of minocycline in clinically isolated syndrome of Multiple Sclerosis 45
Multiple radiculopathy as the presenting manifestation of primary spinal leptomeningeal B cell lymphoma detected by flow cytometry of cerebrospinal fluid. 44
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 38
A Panel of Exploratory CSF Biomarkers in Patients with an Initial Demyelinating Event of the CNS: Does It Add Relevant Information to Usual Work-Up? (P02.080) 35
Totale 7.727
Categoria #
all - tutte 26.349
article - articoli 25.394
book - libri 0
conference - conferenze 312
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 643
Totale 52.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020473 0 0 0 0 0 79 110 35 34 73 44 98
2020/2021870 113 168 49 91 96 90 17 40 38 35 90 43
2021/2022928 84 347 12 120 19 23 10 54 26 18 49 166
2022/20231.588 108 194 138 288 124 361 12 111 172 11 48 21
2023/2024857 29 72 83 84 101 195 26 78 6 33 89 61
2024/2025784 94 127 104 286 108 65 0 0 0 0 0 0
Totale 7.727